A Pijuan-Domènech1, L Galian2, M Goya3, M Casellas3, C Merced3, I Ferreira-Gonzalez2, J R Marsal-Mora2, L Dos-Subirà4, M T Subirana-Domènech5, V Pedrosa4, F Baró-Marine3, S Manrique6, J Casaldàliga-Ferrer4, P Tornos2, L Cabero3, D Garcia-Dorado2. 1. Integrated Hospital Vall d'Hebron-Hospital Sant Pau Adult Congenital Heart Disease Unit, University Hospital Vall d'Hebron, Barcelona, Spain; Department of Cardiology, University Hospital Valld'Hebron, Barcelona, Spain. Electronic address: tonyapijuan@hotmail.com. 2. Department of Cardiology, University Hospital Valld'Hebron, Barcelona, Spain. 3. Department of Obstetrics and Gynaecology, Maternal-Fetal Medicine Unit, University Hospital Vall d'Hebron, Barcelona, Spain. 4. Integrated Hospital Vall d'Hebron-Hospital Sant Pau Adult Congenital Heart Disease Unit, University Hospital Vall d'Hebron, Barcelona, Spain; Department of Cardiology, University Hospital Valld'Hebron, Barcelona, Spain. 5. Integrated Hospital Vall d'Hebron-Hospital Sant Pau Adult Congenital Heart Disease Unit, University Hospital Vall d'Hebron, Barcelona, Spain; Department of Cardiology, University Hospital of Sant Pau I la Santa Creu, Barcelona, Spain. 6. Department of Anesthesiology, Hospital Valld'Hebron, Barcelona, Spain.
Abstract
BACKGROUND/ OBJECTIVE: Several risk scores (RSs) have been used to stratify risk of cardiac complications (CCs) in pregnant patients with heart disease. We aimed to compare and contrast the accuracy of several RSs for predicting CC in this population. METHODS: Prospective inclusion of all consecutive pregnant patients with heart disease, and follow-up until 6 months postpartum. CCs were defined as primary if admission was required due to heart failure, arrhythmia or thromboembolic events, and secondary if the decline in NYHA class compared with baseline was >2 or urgent invasive cardiac procedures were needed. The discriminatory power of each RS was assessed by the area-under-the receiver-operating characteristic (ROC) curve (AUC). RESULTS: 179 patients, mean age: 32 years, accounted for 13.4% of CC (primary 11.7%, secondary 1.7%); the main diagnosis was congenital heart disease (CHD) in 68% followed by valvulopathies in 16%, arrhythmia in 7% and myocardiopathies in 5%. 22% (n=40) were classified as mWHO=1, 59% (n=105) mWHO=2 including subgroup 2-3, 14% (n=26) mWHO=3 and 4%(n=7) mWHO=4; 1 patient was unclassifiable. mWHO showed a better AUC (0.763) than CARPREG (0.67). For the CHD population, ZAHARA RS showed an AUC of 0.74, and Khairy an AUC of 0.632. CONCLUSIONS: mWHO was better at predicting CC than CARPREG; mWHO was also better at predicting CC than the specific CHD RS in the CHD subgroup. PRACTICE: There are an increasing number of pregnant women with HD. IMPLICATIONS: Improved prediction of CC risk during pregnancy can provide better preconception assessment in women with HD.
BACKGROUND/ OBJECTIVE: Several risk scores (RSs) have been used to stratify risk of cardiac complications (CCs) in pregnant patients with heart disease. We aimed to compare and contrast the accuracy of several RSs for predicting CC in this population. METHODS: Prospective inclusion of all consecutive pregnant patients with heart disease, and follow-up until 6 months postpartum. CCs were defined as primary if admission was required due to heart failure, arrhythmia or thromboembolic events, and secondary if the decline in NYHA class compared with baseline was >2 or urgent invasive cardiac procedures were needed. The discriminatory power of each RS was assessed by the area-under-the receiver-operating characteristic (ROC) curve (AUC). RESULTS: 179 patients, mean age: 32 years, accounted for 13.4% of CC (primary 11.7%, secondary 1.7%); the main diagnosis was congenital heart disease (CHD) in 68% followed by valvulopathies in 16%, arrhythmia in 7% and myocardiopathies in 5%. 22% (n=40) were classified as mWHO=1, 59% (n=105) mWHO=2 including subgroup 2-3, 14% (n=26) mWHO=3 and 4%(n=7) mWHO=4; 1 patient was unclassifiable. mWHO showed a better AUC (0.763) than CARPREG (0.67). For the CHD population, ZAHARA RS showed an AUC of 0.74, and Khairy an AUC of 0.632. CONCLUSIONS: mWHO was better at predicting CC than CARPREG; mWHO was also better at predicting CC than the specific CHD RS in the CHD subgroup. PRACTICE: There are an increasing number of pregnant women with HD. IMPLICATIONS: Improved prediction of CC risk during pregnancy can provide better preconception assessment in women with HD.
Authors: Ana Morales; Dawn C Allain; Patricia Arscott; Emily James; Gretchen MacCarrick; Brittney Murray; Crystal Tichnell; Amy R Shikany; Sara Spencer; Sara M Fitzgerald-Butt; Jessica D Kushner; Christi Munn; Emily Smith; Katherine G Spoonamore; Harikrishna S Tandri; W Aaron Kay Journal: J Genet Couns Date: 2017-03-10 Impact factor: 2.537
Authors: Yuli Y Kim; Leah A Goldberg; Katherine Awh; Tanmay Bhamare; David Drajpuch; Adi Hirshberg; Sara L Partington; Rachel Rogers; Emily Ruckdeschel; Lynda Tobin; Morgan Venuti; Lisa D Levine Journal: Congenit Heart Dis Date: 2019-02-06 Impact factor: 2.007
Authors: Betül Toprak; Katharina Govorov; Katinka Kurz; Dora Csengeri; Jessica Weimann; Dennis Witte; Kurt Hecher; Bettina Hollwitz; Anne Hansen; Carsten Rickers; Christina Magnussen; Yskert von Kodolitsch; Tanja Zeller; Stefan Blankenberg; Christoph Sinning; Paulus Kirchhof; Elvin Zengin-Sahm Journal: Cardiovasc Diagn Ther Date: 2021-12